Complete genome sequence of Streptomyces venezuelae ATCC 15439, a promising cell factory for production of secondary metabolites

Ju Yeon Song; Young Ji Yoo; Si Kyu Lim; Sun Ho Cha; Ji Eun Kim; Jung Hye Roe; Jihyun F. Kim; Yeo Joon Yoon

doi:10.1016/j.jbiotec.2015.12.028

Complete genome sequence of Streptomyces venezuelae ATCC 15439, a promising cell factory for production of secondary metabolites

Ju Yeon Song, Young Ji Yoo, Si Kyu Lim, Sun Ho Cha, Ji Eun Kim, Jung Hye Roe, Jihyun F. Kim, Yeo Joon Yoon

Research output: Contribution to journal › Article

12 Citations (Scopus)

Abstract

Streptomyces venezuelae ATCC 15439, which produces 12- and 14-membered ring macrolide antibiotics, is a platform strain for heterologous expression of secondary metabolites. Its 9.05-Mb genome sequence revealed an abundance of genes involved in the biosynthesis of secondary metabolites and their precursors, which should be useful for the production of bioactive compounds.

Original language	English
Pages (from-to)	57-58
Number of pages	2
Journal	Journal of Biotechnology
Volume	219
DOIs	https://doi.org/10.1016/j.jbiotec.2015.12.028
Publication status	Published - 2016 Feb 10

All Science Journal Classification (ASJC) codes

Biotechnology
Bioengineering
Applied Microbiology and Biotechnology

Access to Document

10.1016/j.jbiotec.2015.12.028

Fingerprint Dive into the research topics of 'Complete genome sequence of Streptomyces venezuelae ATCC 15439, a promising cell factory for production of secondary metabolites'. Together they form a unique fingerprint.

Cite this

Song, J. Y., Yoo, Y. J., Lim, S. K., Cha, S. H., Kim, J. E., Roe, J. H., Kim, J. F., & Yoon, Y. J. (2016). Complete genome sequence of Streptomyces venezuelae ATCC 15439, a promising cell factory for production of secondary metabolites. Journal of Biotechnology, 219, 57-58. https://doi.org/10.1016/j.jbiotec.2015.12.028

@article{3ac179a3dba34719a92b6b972e8f9f58,

title = "Complete genome sequence of Streptomyces venezuelae ATCC 15439, a promising cell factory for production of secondary metabolites",

abstract = "Streptomyces venezuelae ATCC 15439, which produces 12- and 14-membered ring macrolide antibiotics, is a platform strain for heterologous expression of secondary metabolites. Its 9.05-Mb genome sequence revealed an abundance of genes involved in the biosynthesis of secondary metabolites and their precursors, which should be useful for the production of bioactive compounds.",

author = "Song, {Ju Yeon} and Yoo, {Young Ji} and Lim, {Si Kyu} and Cha, {Sun Ho} and Kim, {Ji Eun} and Roe, {Jung Hye} and Kim, {Jihyun F.} and Yoon, {Yeo Joon}",

year = "2016",

month = feb,

day = "10",

doi = "10.1016/j.jbiotec.2015.12.028",

language = "English",

volume = "219",

pages = "57--58",

journal = "Journal of Biotechnology",

issn = "0168-1656",

publisher = "Elsevier",

}

TY - JOUR

T1 - Complete genome sequence of Streptomyces venezuelae ATCC 15439, a promising cell factory for production of secondary metabolites

AU - Song, Ju Yeon

AU - Yoo, Young Ji

AU - Lim, Si Kyu

AU - Cha, Sun Ho

AU - Kim, Ji Eun

AU - Roe, Jung Hye

AU - Kim, Jihyun F.

AU - Yoon, Yeo Joon

PY - 2016/2/10

Y1 - 2016/2/10

N2 - Streptomyces venezuelae ATCC 15439, which produces 12- and 14-membered ring macrolide antibiotics, is a platform strain for heterologous expression of secondary metabolites. Its 9.05-Mb genome sequence revealed an abundance of genes involved in the biosynthesis of secondary metabolites and their precursors, which should be useful for the production of bioactive compounds.

AB - Streptomyces venezuelae ATCC 15439, which produces 12- and 14-membered ring macrolide antibiotics, is a platform strain for heterologous expression of secondary metabolites. Its 9.05-Mb genome sequence revealed an abundance of genes involved in the biosynthesis of secondary metabolites and their precursors, which should be useful for the production of bioactive compounds.

UR - http://www.scopus.com/inward/record.url?scp=84951765364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951765364&partnerID=8YFLogxK

U2 - 10.1016/j.jbiotec.2015.12.028

DO - 10.1016/j.jbiotec.2015.12.028

M3 - Article

C2 - 26718561

AN - SCOPUS:84951765364

VL - 219

SP - 57

EP - 58

JO - Journal of Biotechnology

JF - Journal of Biotechnology

SN - 0168-1656

ER -